Skip to content

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03750318
Acronym
RENEW
Enrollment
39
Registered
2018-11-23
Start date
2019-01-31
Completion date
2026-12-31
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Rate, Respiratory Rate, Vital Sign

Keywords

Vital sign monitoring, Heart rate, Respiratory rate

Brief summary

This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system within an adult in-patient setting KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Detailed description

RENEW's Surveillance Monitoring system is made up of two main components: a patient-worn wireless vital signs monitor (Aingeal) that transmits data over Wi-Fi to a central station software platform (Surveillance Station). The Aingeal device measures single lead ECG, heart rate, respiration waveform and rate, and skin temperature. A snapshot of data is transmitted by the devices intermittently to the Surveillance Station, enabling vital signs trends to be plotted. If any heart, respiration rate or skin temperature values move outside of pre-defined high and low limits (individually set for each patient) an alert is raised. ECG arrhythmia detection algorithms automatically record and send ECG data if the patient is suspected to be experiencing an arrhythmia event (Asystole, Ventricular Fibrillation, Tachycardia or Bradycardia). This proposal describes the evaluation of RENEW's Aingeal device within an adult in-patient setting KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Interventions

DEVICEVital sign monitoring

Each patient will be set up for monitoring on admission. Duration of opioid therapy for post-operative in-patients may range from 1-3 days. Once opioid therapy is no longer required, Aingeal monitoring will be ended and each patient would be encouraged to have at least 1 day Aingeal monitoring to be recorded during the study. De-identified log files will be extracted from the Surveillance Station and reprocessed to produce counts of the number of alarms raised during monitoring. A sample of the data will be reviewed to determine whether cardiac and respiratory alarms are defined as True or False, with an overall Alarm Rate per patient per day and False Positive Alarm Rate per patient per day derived. Vital sign trend graphs for each patient will be produced.

Sponsors

KK Women's and Children's Hospital
Lead SponsorOTHER_GOV
Renew Group
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

All patients recruited will be wearing the Aingeal device as part of an integrated monitoring with opioid delivery system at ward setting.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Adult female patients, aged 21 years or over * Patients admitted to post-operative gynaecological ward at KKH Women's and Children's Hospital, Singapore * Patients receiving opioid therapy via patient controlled analgesia (PCA) * Patients that are on electronic nursing charting * Patients that are on acute pain service monitoring

Exclusion criteria

* Patients with active, implantable devices (such as a pacemaker or ICD) * Patients with any skin condition or injury affecting the electrode placement site * Patients that are pregnant (Heart Rate detection algorithm has not been designed to reject foetal heart rate)

Design outcomes

Primary

MeasureTime frameDescription
Overall Respiratory alarm rate per patient per day3-4 days (upon admission till 1-3 days after surgery)De-identified log files will be extracted from the Surveillance Station and reprocessed to produce counts of the number of respiratory alarms raised during monitoring. A sample of the data will be reviewed against the nursing chart to determine whether respiratory alarms are defined as True or False, with an overall Alarm Rate per patient per day derived.

Secondary

MeasureTime frameDescription
Overall Cardiac alarm rate per patient per day3-4 days (upon admission till 1-3 days after surgery)De-identified log files will be extracted from the Surveillance Station and reprocessed to produce counts of the number of cardiac alarms raised during monitoring. A sample of the data will be reviewed against the nursing chart to determine whether cardiac alarms are defined as True or False, with an overall Alarm Rate per patient per day derived.
False positive Respiratory alarm rate per patient per day3-4 days (upon admission till 1-3 days after surgery)De-identified log files will be extracted from the Surveillance Station and reprocessed to produce counts of the number of respiratory alarms raised during monitoring. A sample of the data will be reviewed against the nursing chart to determine whether respiratory alarms are defined as True or False, with False Positive Alarm Rate per patient per day derived.
False positive Cardiac alarm rate per patient per day3-4 days (upon admission till 1-3 days after surgery)De-identified log files will be extracted from the Surveillance Station and reprocessed to produce counts of the number of cardiac alarms raised during monitoring. A sample of the data will be reviewed against the nursing chart to determine whether cardiac alarms are defined as True or False, with False Positive Alarm Rate per patient per day derived.

Countries

Singapore

Contacts

STUDY_DIRECTORBan Leong Sng, FANZCA

KK Women's and Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026